Frontlight ResearchEarly access
Trial site
Szpital Wojewodzki W Opolu Sp. z o.o.
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia3 trials
- Diffuse large B-cell lymphoma3 trials
- Myeloproliferative neoplasms3 trials
- Acute myeloid leukaemia2 trials
- Multiple myeloma2 trials
- Childhood cancers1 trial
- Myelodysplastic syndromes1 trial
- Thalassaemia1 trial
- Phase
- Phase 36 trials
- Phase 1/23 trials
- Phase 23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Recruiting5 trials
- Completed4 trials
- Lead sponsor
- Acerta Pharma BV2 trials
- AbbVie1 trial
- Dizal Pharmaceuticals1 trial
- F. Hoffmann-La Roche AG1 trial
- Genmab1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia2 recruiting
- Childhood cancers1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Thalassaemia1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026